|
1
|
IJkema-Paassen J, Jansen K, Gramsbergen A
and Meek MF: Transection of peripheral nerves, bridging strategies
and effect evaluation. Biomaterials. 25:1583–1592. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kline DG and Hudson AR: Vertebral artery
compression. J Neurosurg. 83:7591995.PubMed/NCBI
|
|
3
|
Lundborg G: Intraneural microcirculation.
Orthop Clin North Am. 19:1–12. 1988.PubMed/NCBI
|
|
4
|
Birch R: Surgery for brachial plexus
injuries. J Bone Joint Surg Br. 75:346–348. 1993.PubMed/NCBI
|
|
5
|
Airaksinen MS and Saarma M: The GDNF
family: signalling, biological functions and therapeutic value. Nat
Rev Neurosci. 3:383–394. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baloh RH, Enomoto H, Johnson EJ and
Milbrandt J: The GDNF family ligands and receptors - implications
for neural development. Curr Opin Neurobiol. 10:103–110. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chu TH and Wu W: Neurotrophic factor
treatment after spinal root avulsion injury. Cent Nerv Syst Agents
Med Chem. 9:40–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Girard C, Liu S, Cadepond F, et al:
Etifoxine improves peripheral nerve regeneration and functional
recovery. Proc Natl Acad Sci USA. 105:20505–20510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barakat-Walter I: Role of thyroid hormones
and their receptors in peripheral nerve regeneration. J Neurobiol.
40:541–559. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gold BG, Udina E, Bourdette D and Navarro
X: Neuroregenerative and neuroprotective actions of
neuroimmunophilin compounds in traumatic and inflammatory
neuropathies. Neurol Res. 26:371–380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Melcangi RC and Garcia-Segura LM:
Therapeutic approaches to peripheral neuropathy based on
neuroactive steroids. Expert Rev Neurother. 6:1121–1125. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schumacher M, Guennoun R, Mercier G, et
al: Progesterone synthesis and myelin formation in peripheral
nerves. Brain Res Brain Res Rev. 37:343–359. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verleye M, Akwa Y, Liere P, et al: The
anxiolytic etifoxine activates the peripheral benzodiazepine
receptor and increases the neurosteroid levels in rat brain.
Pharmacol Biochem Behav. 82:712–720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papadopoulos V, Baraldi M, Guilarte TR, et
al: Translocator protein (18kDa): new nomenclature for the
peripheral-type benzodiazepine receptor based on its structure and
molecular function. Trends Pharmacol Sci. 27:402–409. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karchewski LA, Bloechlinger S and Woolf
CJ: Axonal injury-dependent induction of the peripheral
benzodiazepine receptor in small-diameter adult rat primary sensory
neurons. Eur J Neurosci. 20:671–683. 2004. View Article : Google Scholar
|
|
16
|
Lacor P, Benavides J and Ferzaz B:
Enhanced expression of the peripheral benzodiazepine receptor (PBR)
and its endogenous ligand octadecaneuropeptide (ODN) in the
regenerating adult rat sciatic nerve. Neurosci Lett. 220:61–65.
1996. View Article : Google Scholar
|
|
17
|
Torres SR, Frode TS, Nardi GM, et al:
Anti-inflammatory effects of peripheral benzodiazepine receptor
ligands in two mouse models of inflammation. Eur J Pharmacol.
408:199–211. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Veiga S, Azcoitia I and Garcia-Segura LM:
Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces
reactive gliosis and protects hippocampal hilar neurons from kainic
acid excitotoxicity. J Neurosci Res. 80:129–137. 2005. View Article : Google Scholar
|
|
19
|
Baulieu EE: Neurosteroids: of the nervous
system, by the nervous system, for the nervous system. Recent Prog
Horm Res. 52:1–32. 1997.PubMed/NCBI
|
|
20
|
Ferzaz B, Brault E, Bourliaud G, et al:
SSR180575 (7-chloro-N,
5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]in
dole-1-acetamide), a peripheral benzodiazepine receptor ligand,
promotes neuronal survival and repair. J Pharmacol Exp Ther.
301:1067–1078. 2002.
|
|
21
|
Korneyev A, Pan BS, Polo A, Romeo E,
Guidotti A and Costa E: Stimulation of brain pregnenolone synthesis
by mitochondrial diazepam binding inhibitor receptor ligands in
vivo. J Neurochem. 61:1515–1524. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lacor P, Gandolfo P, Tonon MC, et al:
Regulation of the expression of peripheral benzodiazepine receptors
and their endogenous ligands during rat sciatic nerve degeneration
and regeneration: a role for PBR in neurosteroidogenesis. Brain
Res. 815:70–80. 1999. View Article : Google Scholar
|
|
23
|
Papadopoulos V, Amri H, Boujrad N, et al:
Peripheral benzodiazepine receptor in cholesterol transport and
steroidogenesis. Steroids. 62:21–28. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schumacher M, Robel P and Baulieu EE:
Development and regeneration of the nervous system: a role for
neurosteroids. Dev Neurosci. 18:6–21. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan QW, Yu W, Gong JS, et al:
Cholesterol-dependent modulation of dendrite outgrowth and
microtubule stability in cultured neurons. J Neurochem. 80:178–190.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fan QW, Yu W, Senda T, Yanagisawa K and
Michikawa M: Cholesterol-dependent modulation of tau
phosphorylation in cultured neurons. J Neurochem. 76:391–400. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gudemez E, Ozer K, Cunningham B, Siemionow
K, Browne E and Siemionow M: Dehydroepiandrosterone as an enhancer
of functional recovery following crush injury to rat sciatic nerve.
Microsurgery. 22:234–241. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koenig HL, Gong WH and Pelissier P: Role
of progesterone in peripheral nerve repair. Rev Reprod. 5:189–199.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koenig HL, Schumacher M, Ferzaz B, et al:
Progesterone synthesis and myelin formation by Schwann cells.
Science. 268:1500–1503. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin LF, Doherty DH, Lile JD, Bektesh S and
Collins F: GDNF: a glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons. Science. 260:1130–1132. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin LF, Zhang TJ, Collins F and Armes LG:
Purification and initial characterization of rat B49 glial cell
line-derived neurotrophic factor. J Neurochem. 63:758–768. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duarte EP, Curcio M, Canzoniero LM and
Duarte CB: Neuroprotection by GDNF in the ischemic brain. Growth
Factors. 30:242–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Henderson CE, Phillips HS, Pollock RA, et
al: GDNF: a potent survival factor for motoneurons present in
peripheral nerve and muscle. Science. 266:1062–1064. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arenas E, Trupp M, Akerud P and Ibanez CF:
GDNF prevents degeneration and promotes the phenotype of brain
noradrenergic neurons in vivo. Neuron. 15:1465–1473. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trupp M, Ryden M, Jornvall H, Funakoshi H,
Timmusk T, Arenas E and Ibanez CF: Peripheral expression and
biological activities of GDNF, a new neurotrophic factor for avian
and mammalian peripheral neurons. J Cell Biol. 130:137–148. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Georgievska B, Kirik D, Rosenblad C,
Lundberg C and Bjorklund A: Neuroprotection in the rat Parkinson
model by intrastriatal GDNF gene transfer using a lentiviral
vector. Neuroreport. 13:75–82. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun B, Hui GZ, Guo LH and Reiser J:
Dopaminergic trophism after intrastriatal injection of
lentivirus-transferred GDNF in Parkinson rat model. Sheng Wu Hua
Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 35:937–940.
2003.PubMed/NCBI
|
|
38
|
Saavedra A, Baltazar G and Duarte EP:
Driving GDNF expression: the green and the red traffic lights. Prog
Neurobiol. 86:186–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Behrsing HP and Vulliet PR: Purinergic and
calcium-mediated enhancement of NGF-induced neurite expression in
PC12 cells. Proc West Pharmacol Soc. 42:59–62. 1999.PubMed/NCBI
|
|
40
|
Behrsing HP and Vulliet PR:
Mitogen-activated protein kinase mediates purinergic-enhanced nerve
growth factor-induced neurite outgrowth in PC12 cells. J Neurosci
Res. 78:64–74. 2004. View Article : Google Scholar
|
|
41
|
D’Ambrosi N, Murra B, Cavaliere F, Amadio
S, Bernardi G, Burnstock G and Volonte C: Interaction between ATP
and nerve growth factor signalling in the survival and neuritic
outgrowth from PC12 cells. Neuroscience. 108:527–534. 2001.
|
|
42
|
Soustiel JF, Zaaroor M, Vlodavsky E,
Veenman L, Weizman A and Gavish M: Neuroprotective effect of
Ro5-4864 following brain injury. Exp Neurol. 214:201–208. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mills CD, Bitler JL and Woolf CJ: Role of
the peripheral benzodiazepine receptor in sensory neuron
regeneration. Mol Cell Neurosci. 30:228–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Akwa Y, Schumacher M, Jung-Testas I and
Baulieu EE: Neurosteroids in rat sciatic nerves and Schwann cells.
C R Acad Sci III. 316:410–414. 1993.PubMed/NCBI
|
|
45
|
Ivanova T, Karolczak M and Beyer C:
Estradiol stimulates GDNF expression in developing hypothalamic
neurons. Endocrinology. 143:3175–3178. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Paratcha G and Ledda F: GDNF and GFRalpha:
a versatile molecular complex for developing neurons. Trends
Neurosci. 31:384–391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sariola H and Saarma M: Novel functions
and signalling pathways for GDNF. J Cell Sci. 116:3855–3862. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Paratcha G, Ibanez CF and Ledda F: GDNF is
a chemoattractant factor for neuronal precursor cells in the
rostral migratory stream. Mol Cell Neurosci. 31:505–514. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nielsen J, Gotfryd K, Li S, et al: Role of
glial cell line-derived neurotrophic factor (GDNF)-neural cell
adhesion molecule (NCAM) interactions in induction of neurite
outgrowth and identification of a binding site for NCAM in the heel
region of GDNF. J Neurosci. 29:11360–11376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Enomoto H: Regulation of neural
development by glial cell line-derived neurotrophic factor family
ligands. Anat Sci Int. 80:42–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wissel K, Stöver T, Hofmann NS, et al:
Fibroblast-mediated delivery of GDNF induces neuronal-like
outgrowth in PC12 cells. Otol Neurotol. 29:475–481. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Micallef J, Soubrouillard C, Guet F, Le
Guern ME, Alquier C, Bruguerolle B and Blin O: A double blind
parallel group placebo controlled comparison of sedative and mnesic
effects of etifoxine and lorazepam in healthy subjects [corrected].
Fundam Clin Pharmacol. 15:209–216. 2001.PubMed/NCBI
|
|
53
|
Nguyen N, Fakra E, Pradel V, et al:
Efficacy of etifoxine compared to lorazepam monotherapy in the
treatment of patients with adjustment disorders with anxiety: a
double-blind controlled study in general practice. Hum
Psychopharmacol. 21:139–149. 2006. View Article : Google Scholar
|
